By Samuel Shen and Selena Li
SHANGHAI/HONG KONG, March 24 (Reuters) - A plan by UBS
UBSG.S and China Life Insurance Group to set up an asset
management joint venture in China faces uncertainty as talks
have stalled due to a corruption investigation at the insurer
and curbs set on the scope of the business, two sources said.
China Life's asset management arm and the Swiss bank began
negotiations in late 2020 to jointly form a so-called "wealth
management company" to manage money for mainly retail investors,
Reuters reported in December, citing sources. urn:newsml:reuters.com:*:nL8N2T10SB
The discussions have now stalled, though they have not been
formally called off, said the sources, who had knowledge of the
matter but declined to be identified as they were not authorised
to speak to the media.
The stalling of the talks underscores challenges for western
financial firms looking to expand and grab a bigger share of
China's 100 trillion yuan ($15.70 trillion) asset management
sector, which has opened up for bigger foreign participation.
The talks have cooled as the then Chairman of China Life
Insurance Group, Wang Bin, was put under investigation by the
country's corruption watchdog in January. urn:newsml:reuters.com:*:nL4N2TO030
The development has resulted in a review of planned deals
initiated under Wang's watch, said the sources.
The joint venture talks faded also because the scope of
business for such asset management ventures was overestimated,
said the sources.
UBS had originally hoped that the planned venture would be
able to sell wealth management products (WMPs) via China Life's
army of insurance agents - an idea that was later proven to be
misplaced under new rules for selling of such products published
last year.
The China Banking and Insurance Regulatory Commission
(CBIRC) published rules in 2021 that stipulate only banks and
other deposit-taking financial institutions are allowed to
distribute WMPs.
UBS declined to comment, while a spokesperson for China Life
Insurance Co Ltd 601628.SS , the listed arm of China Life
Insurance Group, did not respond to Reuters' request for
comment.
"We are still pushing, but the progress is behind our
expectations," one of the sources told Reuters, referring to the
status of joint venture discussions.
UBS was looking to hold a majority stake in the venture,
permitted by China in such partnerships since 2019.
China in 2018 allowed banks and other eligible financial
institutions to set up so-called "wealth management companies" -
in essence asset management firms - as part of a campaign to
squeeze risky shadow banking.
An ensuing push by Beijing to lure foreign investors into
the space led to a flurry of deals by global asset managers,
including BlackRock, Amundi, Schroders, and Goldman Sachs, to
form majority-owned ventures with Chinese lenders.
($1 = 6.3677 Chinese yuan renminbi)
(Reporting by Samuel Shen in Shanghai and Selena Li in Hong
Kong; Editing by Sumeet Chatterjee and Muralikumar Anantharaman)
((samuel.shen@thomsonreuters.com; +86 21 20830018; Reuters
Messaging: samuel.shen.thomsonreuters.com@reuters.net))